NETRIN G1 LIGAND: A NEW IMMUNOMODULATORY TARGET AND EARLY BIOMARKER IN PANCREATIC CANCER

$523,663FY2025Defense Health AgencyDOD

Henry Ford Health System, Detroit MI

Investigators